Windlas Biotech Limited

₹994.40As of Sun 8 Nov 2026, 12:00 UTC
NSE:WINDLASHealthcare
Country India
PE (Fwd) •••
TSR 5Y CAGR 20.76%
Div yield 0.63%
ROE 12.09%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.34
PE TTM 31.80
TSR TTM 5.97%
Mkt cap ₹20.52B
ROIC 18.64%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,143
14.96%
(82.05%)
Hold 0|0|7|11|6
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
22.34
23.38
25.11
26.20
24.48%
25.77%
21.89%
20.79%
Revenue₹B
1.285
1.320
1.290
1.254
9.13%
12.36%
4.07%
0.65%
Peers (US$219.2M)
Cap (US$)
PE
231.0M
50.45x
213.2M
14.37x
221.7M
7.989x
Capital
TTM
5Y
10Y
Leveragex
5.195
0.027
0.027
EBIT/Intx
2.869
1.280
1.653
Own earn%
11.16
6.36
(13.36)
Sh yield%
36.47
31.68
31.38
Owners
Insiders/Inst%
11.09
81.53
Short interest%
3.07
SBC / revenue%
5.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
5–9
$1 testx
0.2
Incr. ROIC%
2